News

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...
In DETECT AS, the passive notifications improved rates of AVR and boosted survival, with bigger gains in women.
Large language models (LLM) show promise in supporting clinical decision making, yet the influence of prompt design on ...
Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...
MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...
Dharwad: SDM Narayana Heart Centre, Sattur, Dharwad has successfully provided the sophisticated TAVR treatment to a senior ...
The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, ...
Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.
In a world defined by macroeconomic uncertainty and shifting geopolitical realities, Pella continues to find opportunities.
Finn Akerström; Maria G Barderas; Luis Rodríguez-Padial Disclosures Expert Rev Cardiovasc Ther. 2013;11 (2):239-250.
NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, ...